Similarly, 1, 2, or 5 years of tamoxifen resulted in a decrease in mortality by 14%, 18%, and 28%, respectively, indicating a significant trend towards greater benefits with a longer duration of treatment 27 .
← all excerpts
Trends in the incidence and survival of women with hormone receptor-positive breast cancer from 1990 to 2019: a large population-based analysis.
1
—
—